Run-Lin Gao

Showing 1-7 of 7 articles

Author Jie Qian

Optical coherence tomography assessment of a PLGA-polymer with electro-grafting base layer versus a PLA-polymer sirolimus-eluting stent at three-month follow-up: the BuMA-OCT randomised trial

Qian J, Zhang Y-J, Xu B, Yang Y, Yan H-B, Sun Z-W, Zhao Y-L, Tang Y-D, Gao Z, Chen J, Cui J-G, Mintz G, Gao R

November 20, 2014 | 10.4244/EIJY14M07_17

Author Xiong-Jing Jiang

First-in-man report of a novel dedicated radiofrequency catheter for renal denervation via the transulnar approach

Jiang X-J, Dong H, Liang T, Zou Y-B, Xu B, Gao R

October 25, 2013 | 10.4244/EIJV9I6A111

Author Run-Lin Gao

A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial

Gao R, Xu B, Lansky A, Yang Y, Ma C-S, Han Y-L, Chen S-L, Li H, Zhang R, Fu G, Yuan Z, Jiang H, Huo Y, Li W, Zhang Y-J, Leon M

May 21, 2013 | 10.4244/EIJV9I1A12

Author Run-Lin Gao

Evolution and future perspectives for cardiovascular interventions in China

November 20, 2012 | 10.4244/EIJV8I7A119

Author Bo Xu

Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the NOYA I trial

Xu B, Dou K, Yang Y, Lv S, Wang L, Wang H, Li Z, Wang L, Chen Y, Huo Y, Li W, Kirtane A, Gao R

November 20, 2012 | 10.4244/EIJV8I7A122

Author Ya-Ling Han

A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study

Han Y-L, Zhang L, Yang L-X, Liu H-L, Qu P, Li W-M, Jiang T, Li S-M, Jing Q-M, Zhang Q-Y, Xu B, Li Y, Gao R

November 20, 2012 | 10.4244/EIJV8I7A124

Author Florim Cuculi

Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry

Cuculi F, Banning A, Abizaid A, Bartorelli A, Baux A, Dzavik V, Ellis SG, Gao R, Holmes DR, Jeong M, Legrand V, Neumann F-J, Nyakern M, Spaulding C, Stoll H-P, Worthley S, Urban P

December 30, 2011 | 10.4244/EIJV7I8A152

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more

December 3, 2019

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: DYNAMIC Trial, S3U registry and much more

November 26, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke